At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 370 enrolled
Drug / intervention
Kolofort +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Double-blind Placebo-controlled Randomized Clinical Trial of Efficacy and Safety of Kolofort in the Treatment of Patients With Functional Dyspepsia
In Brief
A Phase 4 clinical trial evaluating Kolofort and Placebo for Dyspepsia. Completed, enrolled 370 participants across 32 sites.
Detailed Summary
Purpose of the study: To obtain additional data on efficacy and safety of Kolofort in the treatment of patients with functional dyspepsia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyspepsia
CountriesRussia
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartJun 2017
Primary CompletionJan 2020
TodayJul 2026
First PostedApr 19, 2017
Enrollment StartJun 28, 2017
Primary CompletionJan 11, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 9.2 years ago
Interventions
Kolofortdrug
Oral administration
Placebodrug
Oral administration